Login / Signup

Synthesis and evaluation of potent (iso)ellipticine-based inhibitors of MYLK4 accessed via expeditious synthesis from isoquinolin-5-ol.

Szu LeeMin-Wu ChaoYi-Wen WuChia-Min HsuTony Eight LinKai-Cheng HsuShiow-Lin PanHsueh-Yun Lee
Published in: RSC advances (2023)
The K 2 S 2 O 8 -mediated generation of p -iminoquinone contributed to the regioselective substitution of isoquinolin-5,8-dione. This hydroxyl group-guided substitution was also applied to selected heterocycles and addressed the regioselectivity issue of quinones. This study has provided an expeditious pathway from isoquinolin-5-ol (5) to ellipticine (1) and isoellipticine (2), which benefits the comprehensive comparison of their activity. Compounds 1 and 2 displayed marked MYLK4 inhibitory activity with IC 50 values of 7.1 and 6.1 nM, respectively. In the cellular activity of AML cells (MV-4-11 and MOLM-13), compound 1 showed better AML activity than compound 2.
Keyphrases
  • acute myeloid leukemia
  • induced apoptosis
  • photodynamic therapy
  • allogeneic hematopoietic stem cell transplantation
  • cell proliferation
  • cell cycle arrest
  • oxidative stress